期刊文献+

川崎病合并无菌性高白细胞尿相关研究 被引量:3

Analysis of sterile pyuria in patients with Kawasaki disease
下载PDF
导出
摘要 目的分析川崎病(KD)合并无菌性高白细胞尿的临床特征及相关发病机制。方法选取住院治疗的420例KD患儿作为研究对象,根据入院尿常规检查将其分为高白细胞尿组(95例)和对照组(325例),对比分析两组的临床资料。结果两组患儿的性别、年龄及不典型KD发生比例的差异均无统计学意义(P均>0.05)。高白细胞尿组的C反应蛋白、D-二聚体、纤维蛋白原降解产物、谷丙转氨酶、谷草转氨酶、尿视黄醇结合蛋白等均高于对照组,差异均有统计学意义(P均<0.05)。两组患儿在入院前平均热程的差异无统计学意义(P?>0.05),但高白细胞尿组入院行丙种球蛋白治疗后发热持续时间更久,差异有统计学意义(P<0.05)。两组患儿在冠状动脉扩张及丙种球蛋白首剂治疗无反应方面的差异也无统计学意义(P>0.05)。结论 KD患儿无菌性高白细胞尿的发病率约为22.6%,伴有高白细胞尿患儿具有更强烈的炎症反应,存在更明显的高凝状态,可能有轻微或亚临床肾损害。 Objectives To explore the clinical features and pathogenesis of Kawasaki disease (KD) combined with sterile pyuria. Methods A total of 420 patients diagnosed of KD were recruited and divided into pyuria group ( 95 patients) and control group ( 325 patients) according to urine routine examination on admission. The clinical data between the two groups were compared. Results There was no difference in gender, age, and the incidence of atypical KD (P all〉0 . 05 ). The levels of C-reactive protein, D-dimer concentrations, fibrinogen degradation products, alanine aminotransferase, aspartate aminotransferase, and urine retinol binding protein were higher in pyuria group than those in control group (all P〉0 . 05 ). No difference was found in the duration of fever before admission between two groups (P〉0 . 05 ). However, pyuria group had longer duration of fever after treatment with immunoglobulin (P〈0 . 05 ). There was no difference in coronary artery lesions and non-response in the ifrst dose of immunoglobulin treatment between two groups (all P〉0.05). Conclusion The morbidity of sterile pyuria in KD patients was 22 . 6%. KD patients with sterile pyuria have more intense inlfammatory response, markedly high coagulation condition, and mild or subclinical renal damage.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2016年第7期494-498,共5页 Journal of Clinical Pediatrics
关键词 川崎病 无菌性高白细胞尿 肾损害 儿童 Kawasaki disease sterile pyuria renal damage child
  • 相关文献

参考文献4

二级参考文献23

  • 1王海,朱允治.37例川崎病X线表现[J].湖南医学,1996,13(5):308-309. 被引量:2
  • 2[1]Kirsztajn GM, Nishida SK, Silva MS, et al. Urinary retinal-binding protein as a prognostic marker in glomerulopathies. Nephron, 2002, 90(4): 424- 431.
  • 3[2]Prevot A, Martini S, Guignard JP.Glomerular filtration markers in pediatrics. Rev Med Suisse Romande, 2002,122(12): 625- 630.
  • 4[5]Craham CS, Michael HW, Christopher MT, et al. Assessment of retinal-binding protein excretion in normal children. Pediatr Nephrol, 1994, 8: 148- 150.
  • 5[6]Dillon SC, Taylor GM, Shah V. Diagnostic value of urinary retinal-binding protein in children nephrotic syndrome. Pediatr Nephrol, 1998, 12: 643- 647.
  • 6[7]Schultz CJ, Dalton RN, Turner C, et al. Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. Diabet Med, 2000, 17(1): 7 - 14.
  • 7[9]Tomlinson PA. Low molecular weight proteins in children with renal disease. Pediatr Nephrol, 1992, 6(6) :565- 571.
  • 8[11]Mastroianni KG, Nishida SK, Ajzen H, et al. Urinary retinal-binding protein as a prognostic marker in the treatment of nephritic syndrome. Nephron, 2000, 86(2): 109-114.
  • 9[12]Valles P, Peralta M, Carrizo L, et al. Follow-up of steroid-resistant nephritic syndrome:Tubular proteinuria and enzymuria. Pediatr Nephrol, 2000, 15(4)252 - 258.
  • 10吴瑞萍 胡来美 江载芳.诸福棠实用儿科学[M]:第6版[M].北京:人民卫生出版社,1996.1857.

共引文献40

同被引文献29

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部